Cart
sales@molnova.com
Chromocarbe
CAS No. 4940-39-0
Chromocarbe( Chromocarb )
Catalog No. M14654 CAS No. 4940-39-0
Chromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 38 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameChromocarbe
-
NoteResearch use only, not for human use.
-
Brief DescriptionChromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections.
-
DescriptionChromocarb is a vascular protective agent used in the treatment of venous disorders and microvascular affections. Peroral treatment of rats with Chromocarb significantly reduces the degradation of the vascular wall by intravenous collagenase. Chromocarb treatment induces a lesser permeability increase of the BBB, a shorter recovery time, lower hydroxyproline levels in the cerebrospinal fluid and a lesser decrease of the collagen content of the brain capillary basal lamina.
-
In Vitro——
-
In Vivo——
-
SynonymsChromocarb
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number4940-39-0
-
Formula Weight190.15
-
Molecular FormulaC10H6O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 38 mg/mL (199.84 mM)
-
SMILESO=C(C1=CC(C2=CC=CC=C2O1)=O)O
-
Chemical Name4-Oxo-4H-1-benzopyran-2-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Godeau G, et al. Clin Physiol Biochem, 1987, 5(1), 15-26.
molnova catalog
related products
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
-
DL5H3
DL5H3 (DL5 H3) is a biochemical.
-
Magnolignan A
Magnolignan A-2-O-beta-D-glucopyranoside has medium cytotoxic activity against HEp-2 and HepG2 cells, with IC(50) of 13.3 microM, and 46.4 microM, respectively.
